Reuters logo
BRIEF-Cascadian Therapeutics Q2 loss per share $0.30
August 8, 2017 / 8:37 PM / 4 months ago

BRIEF-Cascadian Therapeutics Q2 loss per share $0.30

Aug 8 (Reuters) - Cascadian Therapeutics Inc

* Cascadian Therapeutics reports second quarter 2017 financial results

* Q2 loss per share $0.30

* Q2 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S

* Cascadian Therapeutics Inc - ‍expects operating expenses in 2017 to be slightly higher than in 2016​

* Cascadian Therapeutics Inc - ‍cash used in operations for 2017 is expected to be approximately $50.0 million to $54.0 million​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below